Computational biology & AI grants

4-year scheme to develop a strong SPRONG research group on AI-scaling in the public domain. Total call ceiling €2,000,000.

Horizon Europe RIA under the Cancer Mission. Requires development of multiscale AI-integrated Virtual Human Twins for cancer onset, progression and personalised treatment. Proposals must include clinical study annex if clinical studies are envisaged. Interdisciplinary consortia including healthcare professionals, patient representatives, AI experts and SMEs expected. Open science principles mandatory; data must be shared via UNCAN.eu and Advanced VHT Platform.

Call for the second three-year project funding period (2027-2030) of a long-term Infrastructure Priority Programme on new data spaces for social science panel surveys, covering four research areas including AI-based data integration and multimodal data acquisition. Proposals must follow DFG forms 53.01 and 53.200 and be submitted via the elan portal.

Funds mature digital, data-driven and AI-powered healthcare solutions ready to scale across Europe, covering commercialisation pilots, usability testing, go-to-market strategy, health economics and reimbursement pathway development. Funding covers up to 50% of costs; applicants must be legal entities in eligible Horizon Europe countries.

UK applicants must be based at a UK research organisation eligible for EPSRC funding. Proposals must address quantum algorithms/encryption, quantum communications, computing, materials, or sensing. Equipment above £25,000/item and doctoral studentships are not funded. EPSRC funds 80% FEC; no matched funding required beyond standard 20% FEC.

Joint international call supporting collaborative research on quantum technologies (algorithms/encryption, communications, computing, materials, sensing). German applicants at non-university institutions must submit DFG form 55.01 and apply via the elan portal alongside the NSERC submission.

Funds clinical validation (TRL5/6) of already-known cancer biomarkers via multidisciplinary consortia including biostatistician and HTA-expert; mandatory HTA component, patient involvement, and development plan for implementation. AI-component projects must involve the AI4Health consortium as partner or advisor.

Fundamental, speculative, high-risk/high-reward research to advance explainability of future AI systems. UK research organisations only as lead; UKRI funds 80% of FEC (max £602,500 FEC). Fixed project start date of 1 February 2027. Applications particularly welcome from early and mid-career researchers. No PhD studentship costs or equipment >£25k per item. Purely social science, legal, policy or ethical studies are out of scope.

Open to UK research organisations (lead must be at an approved organisation). Funds speculative, high-risk research to improve sustainability of future AI systems (algorithms, hardware, software, architectures). UKRI funds 80% of FEC up to £602,500. Fixed start date of 1 February 2027; no-cost extensions for non-people reasons not permitted. PhD studentship costs and equipment over £25k per item not funded.

Norwegian participation in this EuroHPC call on quantum machine learning is co-funded by the Research Council of Norway with NOK 15 million.

Norwegian participation in this EuroHPC call is co-financed by the Research Council with 15 million kroner.

Supports postdoctoral scientists pursuing hypothesis-driven basic or translational cancer immunology combined with computational biology/data science training. Requires a formal sponsor (assistant professor or higher) and a co-sponsor at a non-profit host institution; no citizenship restrictions but applicants must have <5 years mentored research experience post-PhD.

Supports basic bioscience and biomedicine (molecular biology, cell biology, bioinformatics, genetics, pharmacology, etc.). Research must be conducted at a university, hospital, or non-profit research institution in Denmark. DKK 12M earmarked for the strategic theme 'Microbiota-host interactions: from molecular mechanisms to their role in physiology'.

Open to researchers at HRB-approved Host Institutions in Republic of Ireland (Northern Ireland excluded). Transnational consortia required. Focuses on diagnosing rare genetic and non-genetic diseases via multi-omics, AI, and systems biology. Excludes interventional clinical trials, basic biomedical research, pre-clinical therapy development, and PhD funding. Tobacco/alcohol industry-linked applicants ineligible.